Figure 5. 100%, horizontally-stacked, utilization-adjusted bar chart of
efficacy and safety. The vertical height of each bar is proportional to
the number of patients in the cohort for 4 years of follow up. The
number of patients experiencing the events of interest are represented
as proportions within each bar. Event proportions are unadjusted for
confounding factors.
Drug A: Apixaban, Drug B: Rivaroxaban, Drug C: Warfarin